FABP7 and glioblastoma: Treatment of U251 human glioblastoma cells with AA promoted αSyn aggregation in an FABP7-dependent manner, and a high affinity FABP7 synthetic ligand disrupted the FABP7–αSyn interaction and reduced αSyn oligomerization, thereby rescuing glial cells from cell death (20).